Application of a Filtration- and Isolation-by-Size Technique for the Detection of Circulating Tumor Cells in Cutaneous Melanoma

被引:127
作者
De Giorgi, Vincenzo [1 ]
Pinzani, Pamela [2 ]
Salvianti, Francesca [2 ]
Panelos, John [3 ]
Paglierani, Milena [4 ]
Janowska, Agata [1 ]
Grazzini, Marta [1 ]
Wechsler, Janine [5 ,6 ]
Orlando, Claudio [2 ]
Santucci, Marco [4 ]
Lotti, Torello [1 ]
Pazzagli, Mario [2 ]
Massi, Daniela [4 ]
机构
[1] Univ Florence, Dept Crit Care Med & Surg, Dermatol Unit, I-50100 Florence, Italy
[2] Univ Florence, Dept Clin Physiopathol, Clin Biochem Unit, I-50100 Florence, Italy
[3] Univ Ioannina, Sch Med, Dept Pathol, GR-45110 Ioannina, Greece
[4] Univ Florence, Dept Crit Care Med & Surg, Div Anat Pathol, I-50100 Florence, Italy
[5] Henri Mondors Univ Hosp, Dept Pathol, Creteil, France
[6] Screencell, Paris, France
关键词
POLYMERASE CHAIN-REACTION; TYROSINASE MESSENGER-RNA; PERIPHERAL-BLOOD; MALIGNANT-MELANOMA; REVERSE-TRANSCRIPTASE; PROGNOSTIC VALUE; MOLECULAR MARKERS; CANCER PATIENTS; BREAST-CANCER; RT-PCR;
D O I
10.1038/jid.2010.141
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Analysis of circulating tumor cells (CTC) in the peripheral blood of cutaneous melanoma patients provides information on the metastatic process and potentially improves patient management. The isolation by size of epithelial tumor cells (ISET) is a direct method for CTC identification in which tumor cells are collected by filtration as a result of their large size. So far, ISET has been applied only to CTC detection from epithelial cancer patients, and the technique has never been applied to cutaneous melanoma patients. We herein investigated the presence of CTC by ISET in the peripheral blood of 140 subjects (87 with cutaneous melanomas, 10 subjects undergoing surgery for melanocytic nevi, 5 patients with non-melanoma skin tumors, and 38 healthy volunteers). The identification of the cells trapped in filters as CTC was supported by positivity for immunohistochemical markers and for tyrosinase mRNA by real-time RT-PCR. CTC were neither detected in the controls nor in the in situ melanoma group. In contrast, CTC were shown in 29% of patients with primary invasive melanoma and in 62.5% of metastatic melanoma patients (P<0.01). CTC detection correlated with the presence of mRNA tyrosinase in blood samples, assayed by real-time RT-PCR (P=0.001). CTC detection corroborated by suitable molecular characterization may assist in the identification and monitoring of more appropriate therapies in melanoma patients.
引用
收藏
页码:2440 / 2447
页数:8
相关论文
共 36 条
[1]   Circulating Tumor Cells in Solid Cancer: Tumor Marker of Clinical Relevance? [J].
Bertazza, Loris ;
Mocellin, Simone ;
Nitti, Donato .
CURRENT ONCOLOGY REPORTS, 2008, 10 (02) :137-146
[2]   The current epidemiology of cutaneous malignant melanoma [J].
Berwick, M ;
Wiggins, C .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 :1244-1254
[3]   Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled-polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma [J].
Brownbridge, GG ;
Gold, J ;
Edward, M ;
MacKie, RM .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (02) :279-287
[4]   CELL-SURFACE ANTIGENS OF HUMAN MALIGNANT-MELANOMA - MIXED HEMADSORPTION ASSAYS FOR HUMORAL IMMUNITY TO CULTURED AUTOLOGOUS MELANOMA CELLS [J].
CAREY, TE ;
TAKAHASHI, T ;
RESNICK, LA ;
OETTGEN, HF ;
OLD, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (09) :3278-3282
[5]   MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases [J].
Curry, BJ ;
Myers, K ;
Hersey, P .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2562-2571
[6]   Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study [J].
Eschwege, P. ;
Moutereau, S. ;
Droupy, S. ;
Douard, R. ;
Gala, J-L ;
Benoit, G. ;
Conti, M. ;
Manivet, P. ;
Loric, S. .
BRITISH JOURNAL OF CANCER, 2009, 100 (04) :608-610
[7]   Diagnosis and treatment of cutaneous melanoma: state of the art 2006 [J].
Garbe, Claus ;
Elgentler, Thomas K. .
MELANOMA RESEARCH, 2007, 17 (02) :117-127
[8]  
Ghossein RA, 1998, CLIN CANCER RES, V4, P419
[9]   Prognostic significance of the sequential detection of circulating melanoma cells by RT-PCR in high-risk melanoma patients receiving adjuvant interferon [J].
Gogas, H ;
Kefala, G ;
Bafaloukos, D ;
Frangia, K ;
Polyzos, A ;
Pectasides, D ;
Tsoutsos, D ;
Panagiotou, P ;
Ioannovich, J ;
Loukopoulos, D .
BRITISH JOURNAL OF CANCER, 2002, 87 (02) :181-186
[10]  
Hoon DSB, 2000, CANCER RES, V60, P2253